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1. Introduction  
The natural history of infection with human immunodeficiency virus (HIV) has changed 
with the introduction of antiretroviral therapy (Fischl et al 1987), these drugs have the 
ability to inhibit viral replication and immune recovery of infected patients (Lalezari et al 
1999). This has resulted in reduced mortality and morbidity caused by this viral infection 
(Mellors et al 1996). The human immunodeficiency viruses have extraordinary structural 
and evolutionary complexity since its original identification and description for over 25 
years. Nine subtypes are known and three different subtypes, a total of 12, with subtype C 
HIV-1 responsible for more than half of infections in the world. The molecular and genetic 
study of HIV reflects the enormous and increasing variability of these organisms (Hue et al 
2005). 
The HIV viruses are highly variable and are adapted to the selective pressure of 
antiretroviral drugs, hence antiviral treatments, which started 19 years ago have selected 
strains with resistance mutations that complicate or invalidate the continuity of certain 
treatments and sometimes of all. 
The geographical distribution and the percentage in the distribution of transmission 
pathways of the disease have changed over the past 25 years that have elapsed since the 
start of the epidemic (CDC, 2002). AIDS is an emerging disease in countries of the former 
Soviet Union, China, and sub-Saharan countries, the number of children and adults who are 
being infected is higher, producing a characteristic accelerating effect of prolonged 
epidemics. The AIDS program of the United Nations estimates that by the end of 2005, the 
total number of people worldwide living with HIV-/-AIDS was 40.3 million, 64% are in sub-
Saharan Africa (WHO, 2005). In Europe 294,571 cases were reported in late 2004, 18.6% were 
women and 3.7% were children. The main transmission groups in Europe are injecting drug 
users (38.1%), homosexual contacts (29.5%), and heterosexual contacts (20%), although these 
parameters are not evenly distributed across the continent. While there has been an overall 
decrease of 6.7% over the previous year 2004 (HIV EURO 2005). In Mexico, the first case was 
diagnosed in 1983 and currently the largest number of cases (38.400) live in Mexico City, 
that is 17% of all HIV cases in the country for 2010. The age of onset is 15 to 49 years, 87% 
are men and 13% are women. The main route of infection is homosexual practice. In this 
country, AIDS is the third leading cause of death nationally among men 25 to 34 years and 
the sixth among women in this age group (http: // www. aid-sida-org/estadistic05.htlm). 
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The clinical presentation of AIDS varies from one geographic area to another according to 
the most prevalent transmission groups. 
The purpose of this chapter is to conduct a general review of infectious agents and 
neoplasmas associated with some viral agents in the era of antiretroviral treatment of HIV-
infected patients in specimens obtained by biopsy, surgical resection, or cytology material. 
2. HIV infection 
HIV infects several human cell types such as macrophages and glial cells, but its real target 
cell is the lymphocyte CD4+ and the following pathogenic processes divided into three 
periods can be disthinguished. 
Primary infection during which the virus spreads to lymphoid organs. It is characterized by 
high levels of viremia and lasts between two and six weeks, patients have nonspecific 
symptoms. A few days after the initial infection occurs, they produce large amounts of viruses 
in activated lymphocytes from the lymph nodes, causing inflammation in the nodal lymphoid 
tissue. The first reaction of immunity against infection is provided by CD8+ cytotoxic 
lymphocytes, or CTL, which lyse infected cells that present viral antigens on their surface. The 
virus is never removed during primary infection, since it maintains a residual viral replication, 
which is detected in plasma or lymph nodes. Escape mutants seem to evade, by mutation in 
certain epitopes, the immune pressure of helper T lymphocytes and memory cells, there by 
escaping destruction CTL (Stremlau et al 2004). A few weeks after infection, there is a 
significant depletion of CD4+ cells in the digestive tract, long before CD4+ levels in blood are 
altered. One explanation for this activity in the gastrointestinal tract could be because cells in 
this area have the co-receptor CCR5, which is used by HIV to infect cells. (Pierson et al 2002) 
The second period is the chronic asymptomatic infection, the average duration of this phase 
is 10 years, it is characterized by stable levels of CD4+ with a tendency to decrease 
progressively, the viral load drops and may be undetectable, but the virus continues its 
replication in the lymphoid tissue. The causes of decline in CD4+ cells during this phase of 
infection are only partially known. The increase in viral load and decreased CD4+ during 
this phase correlate inversely, but sometimes describe curves of complex kinetics that 
suggest the presence of multiple factors that influence the lysis of infected lymphocytes and 
the production of new virus particles. CD8+ lymphocytes remain slightly increased during 
this phase, indicating the existence of cytotoxic reactions against the virus and viral antigens 
are detected in follicular dendritic cells. Viral sub-populations become more heterogeneous. 
Advanced HIV infection or AIDS. At this stage of the disease, the individual develops 
opportunistic infections, as CD4+ lymphocyte counts are lower than 200/µl viral replication 
is accelerated, the activity of anti-HIV CTL declines, and lymphoid morphology is 
destroyed. Lymphoid tissue degeneration may be due to replication of the virus, or may be 
an indirect consequence of chronic immune stimulation. Neurological tropism of the 
infection is observed and produced viruses are less sensitive to neutralizing antibodies. 
3. Opportunistic infections 
Among the most common opportunistic infections in Mexico and Spain are tuberculosis, 
Pneumocystis carinii pneumonia and esophageal candidiasis (Secretariat of the National 
Plan on AIDS 2005). While the introduction of new triple therapies have increased survival 
of patients infected with HIV, AIDS remains a disease with high mortality rate. Most 
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opportunistic infections occur as reactivation of latent infections that reappears when the 
immune system can no longer control them. The current frequency of opportunistic 
infections varies in different regions and have declined due to active antiretroviral therapy 
(HAART) (Kaplan et al 2000). From 15 to 30% of non treated HIV-infected patients develop 
pneumonia during the course of the disease caused by Pneumocystis jiroveci. Today 
opportunistic infections are less common in patients who respond to treatment with 
HAART. Among infections not associated with AIDS are some that appear in the general 
population, and have a higher incidence in patients with HIV infection, such as 
pneumococcal pneumonia, oropharyngeal candidiasis, or herpes zoster. A list of viral, 
bacterial, and fungal microorganisms that occur in patients with AIDS exists. These can even 
occur in patients with antiretroviral treatment and immune imbalance. (Table 1). 
There are differences in the prevalence and incidence of some diseases that can be attributed to 
the characteristics of the population, climate, endemic diseases, to standards of hygiene, and 
medical care availability and pharmacology, as well as to socioeconomic and cultural factors. 
 
 
Table 1. 
3.1 Description of opportunistic microorganisms 
3.1.1 Mycoses 
Fungal infections are common in patients with HIV infection. Morbidity and mortality are 
influenced by antiretroviral treatment because of the close relationship between the degree 
of immunodeficiency, the frequency, and severity of fungal infections. 
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The advent of HAART and new antifungal agents, such as voriconazole and caspofungin, 
have decreased the incidence of fungal infections associated with HIV. Although, the causal 
agent  can be   clinically suspected, samples can be collected from some body fluids and 
other sites  for the  diagnosis, as for example puncture-/-aspiration of abscesses, puncture of 
cerebrospinal fluid, and from bile, pericardial, pleural, peritoneal, liquids. Bone marrow 
aspiration, nails, sputum, biopsies of deep tissues or skin, urine and blood. In tissues, the 
opportunistic organism can be suspected but to know the etiological agent, cultures must be 
made. (Romani 2004) 
Fungal Yeasts: Candida and Cryptococcus Genera. 
Candidiasis is the most common fungal infection in these patients, the most common clinical 
presentation of oropharyngeal candidiasis and vaginal candidiasis in women, occurs with 
greater frequency and severity than in the rest of the population and they are recurrent. 
Usually the diagnosis is clinical, by positive culture or visualization of the yeast through 
Gram staining. In the cervico-vaginal smears. Candida sp. can be morphologically suspected 
by the presence of yeasts and spores in the cellular smears and observing abundant 
inflammatory infiltration of polymorphonuclear cells. When the patient presents 
oropharyngeal candidiasis and dysphagia, diagnosis can be made by endoscopy and biopsy. 
Finally, invasive candidiasis is uncommon in AIDS patients, but, when present, bronchial or 
pulmonary candidiasis is observed in the final stages of the disease. (Whiteway et al, 2004). 
Cryptococcus neoformans is a worldwide distributed yeast of, spherical shape produced by 
a single budding unique and posesses a mucopolysacharide capsule that confers virulence. 
Depending on the capsular polysaccharides four serotypes named A, B, C, and D have been 
described. According to these serotypes, there are two varieties: C. neoformans (serotypes A 
and D), which is the most common in patients with AIDS and C. vargatti neoformans 
(serotypes B and C). Exposure to the organism is frequent and the route of entry is the 
respiratory tract. The most common clinical form is meningoencephalitis and two-thirds of 
patients course with extrameningeal dissemination C. neoformans may disseminate widely 
to the skin, liver, spleen, adrenals and bones. The fungi induce a chronic granulomatous 
reaction comprising macrophages, lymphocytes, and foreign body-type giant cells. 
Suppuration also may occur, as well as a rare granulomatous arteritis of the circle of Willis. 
The diagnosis is made in the positive culture of cerebrospinal fluid or blood (Fig.1).  
When evaluating the cerebrospinal fluid cytology, it is possible to observe the characteristics 
of encapsulated yeasts. The capsule does not stain with standard dyes, making it necessary 
to use china ink or Mayer's mucicarmine. The sensitivity of the test can reach 75%. 
Cryptococcosis is higher among HIV-infected persons with fewer than 100 CD4+ 
lymphocytes/µl (Eisenman et al 2007). 
 
Aspergillus sp 
The incidence of invasive aspergillosis in patients infected with HIV is very low due to the 
spread of highly active antiretroviral therapy (HAART). Risk factors include neutropenia 
and steroid therapy. Aspergillus fumigatus is the most common species to cause disease, 
and it produces severe invasive infections in immunocompromised individuals. The usual 
location is the lung. Diagnosis is difficult because the isolation of Aspergillus sp from 
respiratory secretions has little value: when respiratory symptoms and pulmonary infiltrates 
are present, the value of Aspergillus sp. isolation  from respiratory secretions increases. The 
detection of antigens such as galactomannans by ELISA or beta-1-3 glucan is more valuable. 
Another diagnostic test with a great potential is the polymerase chain reaction (PCR). 
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Fig. 1. Cryptococcus neoformans in cerebrospinal fluid. (40X China ink) 
Morphology: Colonizing aspergillosis (aspergilloma) usually implies growth of the fungus 
in pulmonary cavities with minimal or no invasion of the tissues. Invasive aspergillosis is an 
opportunistic infection that is confined to immunosuppressed hosts. The primary lesions are 
usually in the lung, but widespread hematogenous dissemination with involvement of the 
heart valves and brain is common. Definitive diagnosis requires histological demonstration 
of hyphae in tissue and can be more evident if special stains such as periodic acid-Schiff and 
silver stains are performed, but the fungus must be isolated from sterile samples. 
Sporothirx schenckii. 
Sporotrichosis is an uncommon infection. The most common form of infection is cutaneous 
inoculation by contaminated sharps objects and clinical diagnosis is facilitated by the typical 
lymphocutaneous lesions. Recommended tests for diagnosis should be a skin biopsy and 
analysis of the purulent material. The pulmonary, musculoskeletal, and other less common 
forms occur in patients with cellular immunosuppression. The diagnosis is clinical, 
morphological, and through cultures. 
Histoplasma capsulatum. 
This microorganism is distributed in the American continent, but in Africa there is a variant 
of the disease caused by H. capsulatum, variety duboisii. It is a dimorphic fungus and 
produces common endemic mycosis in HIV-positive patients. The primary infection occurs 
by conidia inhalation. There are three clinical forms: acute primary infection, pulmonary 
cavity and acute disseminated infection, which is the most frequent in AIDS patients. The 
diagnosis is made by culture of respiratory, bone marrow samples, or by biopsy of lymph 
node, liver, lung, or skin (Fig.2). Methenamine-silver and PAS stainings are useful for its 
detection in biological fluids and tissues. It in tissue from patients with AIDS, abundant 
organisms in macrophages can be observed, in general there is no chronic granulomatous 
reaction. (Isenberg, 2004) 
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Fig. 2. Histoplasmosis in macrophages in a cervical lymph node. Aspiration biopsy. (PAS 
stain 40X)  
Coccidioides immitis. 
It is the causal agent of coccidioidiomicosis. It is a dimorphic fungus and is found in temperate 
areas of the American continent. The disease is acquired by inhalation of arthroconidia or 
cutaneous inoculation. There are three clinical forms: cutaneous, asymptomatic, and the 
disseminated form. The disseminated form was common before the era of HAART in endemic 
areas. The diagnosis is based on direct examination and culture of sputum, blood, broncho-
alveolar lavage, skin and others. In tissue, spherules with endospores are observed and, as in 
other mycoses, special stains must be performed to identify the organism. 
Blastomyces dermatitidis 
This is a dimorphic fungus. Its natural habitat is the North American continent, although 
cases have been reported in Africa, Asia, and Europe. The initial infection is pulmonary, 
when  there is hematogenous spread, it may affect the skin, bones, genitourinary and central 
nervous systems. In a fresh examination of sputum, skin lesions, or biopsy material 
characteristic yeast-like elements can be observed that allow for the presumptive diagnosis.  
Other dimorphic fungi that occur in HIV patients in specific regions, such as Brazil and China, 
are Paracoccidioides brasiliensis and Penicillium marneffei, respectively (Patrick, 2003). 
3.1.2 Virus infections 
Cytomegalovirus. 
The diagnosis of cytomegalovirus (CMV) must to rely on laboratory tests. Among the 
diagnostic tests used are: serological diagnosis, which a little use in HIV-positive patients. 
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Latex agglutination, or ELISA methods are recommended. Direct detection of the virus or its 
antigens. Cytological and histological techniques have insufficient sensitivity. However, it is 
the method of choice for CMV gastrointestinal involvement. If an immunohistochemical 
technique is used, it can improve the specificity. When there is lung disease, cytopathic 
changes can be observed in cells obtained from bronchial lavage or sputum. The culture is 
the gold standard for its specificity for the diagnosis of active infection.  
Cytomegalovirus affection caused widespread disease and caused severe damage to the 
eyes and the gastrointestinal tract, chorioretinitis appeared in 25% of patients with HIV 
before the advent of HAART, but the condition has declined dramatically (Gerner, et al 
1990). The condition of the gastrointestinal tract is observed in 5 to 10% of cases and 
manifests as ulcerative esophagitis. Detection in biopsies has a positive predictive value, but 
due to insufficient sensitivity of the samples are should be taken with the diagnosis through 
this route, ideally tissue should be used, being PCR the most sensitive technique for the 
diagnosis (Gleaves et al 1984). 
Herpes simplex virus and varicella-zoster virus. 
The diagnosis of infections with herpes simplex virus (HSV) and varicella zoster virus is 
basically through clinical criteria, but the severity of some cases or atypical clinical 
presentation warranted to confirm the diagnosis with laboratory tests (Ashley 1989). 
The samples for diagnosis of viral infection are obtained by scraping and taking smears of 
mucocutaneous lesions, but also by biopsies and respiratory samples. 
The affection caused by the herpes simplex virus is manifested by mucocutaneous ulcers in 
lips, esophagus, external genitals and perianal region. It is possible to see the cytopathic 
effect on a smear of the mucocutaneous ulcer (Fig. 3) 
 
 
Fig. 3. Herpex simplex virus with cell inclusions or cytophatic effect in perianal region. (40X 
Papanicolaou stain) 
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Amplification by PCR is the method of choice for the diagnosis of central nervous system 
infections in the case of infection with varicella zoster virus. (Gerson et al 1991) 
JC polyomavirus. 
Compared to other opportunistic infections, new antiretroviral therapies have not had much 
impact on the occurrence of progressive multifocal leukoencephalopathy. It is possible to 
observe this complication even in patients virologically stable and the prognosis remains 
unfavorable. The diagnosis is clinical, supplemented by imaging studies and, at times, with 
histopathologic examination. Virological diagnosis is restricted to few laboratories and to 
the use of molecular techniques and electron microscopy. 
The samples for the diagnosis are obtained from cerebrospinal fluid biopsies or from 
autopsies of patients who died from the disease (Athur et al 1989). 
3.1.3 Mycobacterial infections: Mycobacterium tuberculosis and non tuberculous 
mycobacteria 
The diagnosis of tuberculosis in HIV-infected patients may be difficult for many reasons,  
for the multiple atypical clinical and radiological presentations, negative value of the PPD 
cutaneous  reaction, less sensitive bacilloscopies, and on the  other hand by the appearance 
of multidrug-resistant M. tuberculosis strains, possible malabsorbtion, and the disturbing 
interaction between protease inhibitors and rifampicin. Besides the infection caused by 
tuberculosis mycobacteria (M.tuberculosis and M. bovis), infection caused by non-
tuberculous mycobacteria are frequent in AIDS patientes. Of these the mycobacteria of the 
avium-intracellulare complex, which constitute the most important pathogen group, where 
disseminated disease was one of the most common opportunistic infections in these 
patients. Treatment with antiretrovirals has greatly decreased the disseminated disease 
mainly in the United States. Diagnosis is made in the following samples: simple or 
spontaneous sputum tissues (lymphoid tissue biopsies or lung) in sterile liquid such as 
pleura, pericardium and urine (Pfyffer et al 2003). Molecular biology techniques increases 
diagnostic sensitivity. In the tissue numerous acid-fast bacilli in alveolar macrophages or 
tissue are identified, and chronic granulomatous reaction in patients with advanced disease 
is absent (FTAA and Telent, 1997) (Fig. 4 and Fig. 5). 
Other bacterial infections in HIV patients are syphilis caused by Treponema pallidum that 
causes ulcerative lesions and papules in the genital and anorectal areas. 
Biopsy specimens of tissue or lymph node involvement may reveal the presence of 
treponema, which are apparent with the help of special stains for bacteria or by direct 
immunofluorescence. (Musher et al 1990). 
Some antiretroviral drugs cause other diseases, such as, lipodystrophy and immune 
reconstitution syndrome, the clinical manifestations are mainly cutaneous (Mudroch et al 
2008) 
More than half of the manifestations of immune reconstitution syndrome occur in the skin. 
It has been reported that 10 to 25% of patients starting antiretroviral treatment suffer from 
this syndrome 90 days later (Rodwell, et al 2008). The most common diagnoses are 
folliculitis for any reason, reactivation of herpes virus infections, and molluscum 
contagiosum. Fungal infections, such as ringworm infections of the body and head, as well 
as systemic mycoses caused by Cryptoccocus (Lehloenya and Mentjes 2006). 
It is important to take into account the latter cutaneous manifestations in patients with 
AIDS. 
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Fig. 4. Lymph node  histologic section with histiocytes and lymphocytes in a patient with 
atypical Mycobacterium. (H-E 10X) 
 
Fig. 5. Sheets of foamy macrophages are seen, which are packed with Mycobacterium 
demonstrated with acid-fast stains (10X)  
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4. Neoplasms 
The common malignancies in HIV patients are associated with oncogenic DNA viruses like 
Epstein-Barr virus, Human Herpes virus 8, and human papilloma virus, related to non-
Hodgkin and Hodgkin lymphomas, Kaposi's sarcoma, and squamous cell carcinomas  such 
as cervical and anal carcinomas (Table 2). 
 
 
Table 2. 
4.1 Kaposi sarcoma 
Kaposi sarcoma (KS) is the most common malignancy in these patients, affecting 
homosexual individuals, but can be seen in any patient with HIV (Mitsuyasu 1990). In recent 
years, various studies have suggested that the herpes virus HHV-8 plays an important role 
in the pathogenesis of epidemic, endemic, African, and immunosuppressed Kaposi's 
sarcoma. It has also been observed in lymphomas cavities (Engels et al 2003). The incidence 
of KS has declined in recent years with the use of HAART; in most patients it presents with 
skin lesions, lymph node involvement and less commonly, oral mucosal or gastrointestinal 
tract lesions. In over 50% of patients with cutaneous KS, visceral involvement can be 
www.intechopen.com
 Surgical Pathology in HIV Infection in the Era of Antiretroviral Therapy 223 
detected, such as small intestine and colon. Other affected organs are lung, lymph nodes, 
liver, heart, and brain. 
Histologically, KS lesions are characterized by a proliferation of spindle cells forming 
vascular channels and expressing markers for endothelial cells and smooth muscle cells (Fig 
6). Another change observed is the presence of chronic inflammatory infiltrate. It is believed 
that the injuries can come from a primitive mesenchymal precursor cell vascular channel. In 
the pathogenesis of KS, it is believed that spindle cells produce pro-inflammatory and 
angiogenic factors (Ganem 2006). Clinically, KS is more aggressive in HIV patients than in 
the sporadic form of the disease. 
 
Fig. 6. Kaposi Sarcoma proliferation of spindle cells and vascular channels (H-E10X) 
4.2 Lymphomas in HIV patients 
The first cases of non-Hodgkin lymphoma (NHL) in patients with HIV infection were 
reported in homosexual subjects in l982 and the first multicenter study of NHL in patients 
with HIV infection was published in 1984 (Ziegler et al 1984). 
4.3 Non-Hodgkin lymphomas 
In recent years we have recognized certain subtypes of uncommon NHL that appears 
almost exclusively in patients with HIV infection, such as primary effusion lymphoma, 
other types of lymphomas have peculiar clincopathological characteristics possibly as a 
result of immunosuppression. (Goedert  et al 1998) These include Hodgkin lymphoma (HL), 
diffuse large B cell lymphomas, plasmablastic lymphoma (Selik and Rabkin 1998). Other 
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lymphomas described in these patients in which no increased incidence has been described 
are: MALT-type marginal zone B lymphoma of the digestive tract, lymphoplasmacytoid 
lymphoma, chronic lymphocytic leukemia, solitary bone and extramedullary plasmacytoma,  
and immature T lymphomas  (lymphoma/ lymphoblastic leukemia) and mature such as the 
perpheral unespecific T lymphoma, and in our country the  nasal type lymphoma T / NK 
(Gonzalez  et al 1998) (Tirelli  et al 1995). Other hematological malignancies often described 
with variable frequencies are some leukemias myeloblastic and chronic myeloproliferative 
syndromes. Among non-neoplastic lymphoid processes are the multicentric Castleman 
disease, the CD 8 lymphocytosis syndrome, lymphoid interstitial pneumonitis and the 
polymorphous polyclonal lymphoproliferative disease B. (Table 2). 
Lymphomas in patients with HIV infection are heterogeneous and often result from 
complex and sequential interaction of several factors (Knowles 1999; Baiocchi1999), such as 
chronic antigenic activation of B lymphocytes, where maintained stimulation and 
proliferation of B lymphocytes can be induced by the HIV infection itself, but other 
mechanisms exist mostly viral, as well as the continuous production of cytokines in 
response to infection by HIV. High serum concentration are detected of the following 
interleukins: IL-6, IL-10, and IL-12; it is though that these cytokines are relevant in the 
polyclonal expansion phase of B lymphocytes. Another factor associated is dysregulation of 
cytokines and of costimulatory networks, and oncogenic viruses infection. 
Of the viruses that have been associated with neoplasmas , there are two implicated in the 
genesis of NHL, that is, the (EBV) and the human herpes virus type 8 (HHV-8). All viruses 
with oncogenic capacity share the feature of being in the organism either in their latent stage 
or as a chronic infection. The mechanisms by which the EBV participates in the genesis of 
lymphomas is as follows. In normal subjects, when they become infected with EBV they 
undergo seroconversion during the first decade of life. Primary infection is usually 
asymptomatic and the virus persists along the whole life. It enters the host by infecting B 
lymphocytes through the CD 21 (receptor of CD 3d) and persists in latent form after DNA 
adopts an extra-chromosomal (episome) circular shape (Anagnastopoulos et al 1999). In this 
stage, nine proteins and two non-coding small RNA, known as EBER 1 and 2, of unknown 
function can be expressed. Combination of the different proteins yield the three  types of 
EBV latency (Lyons and Liebowitz, 1998), where EBNA 2 and LMP-1 (latent membrane 
protein- 1) are the most important considereing their transforming capacity exert on B 
lymphocytes. According to the presence of protein EBNA-2, two types of EBV are identified 
with different transforming activity. The most active is type 1 (Anagnastopulos et al 1999). 
In lymphomas, there is only one variant of the EBV, usually type 1 in the diffuse large B cell 
lymphomas, and type 2 in Burkitt´s lymphoma (Ometto et al 1997). The finding of viral 
episomes of a single type or clones in a given lymphoma indicates that the virus was present 
in the tumor cells at the start, and that it is probable relevant in its pathogenesis (Lyons and 
Liebowitz, 1998).   
Factors that contribute to the development of the NHL act in stages and successively. After 
the initial stage of increased B lymphocytes proliferation follows one of oligoclonal B 
expansions, genetic alteration are introduced that conclude in a lymphoma (Gaidano et al 
1998). When expressed in B lymphocytes, LMP-1 aggregates to the cell membrane and, just 
like CD 40, reacts with TNF (tumor necrosis factor) associated factors (TRAF), which 
translate the signal and activate the NK-kb transcriptional factor (Rickinson 1998). Binding 
of protein LMP-1 with TRAF (TNF associated factors) is the major determinant of the 
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transforming activity of B lymphocytes and as substances implicated in tumor invasion  and 
in metastases (ICAM-1-LFA-3, metalloproteinases, among others). EBV infection is only one 
step in NHL genesis in HIV patients. In Burkitt´s lymphoma, EBV is present in a third of 
cases it has a type 1 latency, rarely LMP-1 protein is positive, since activation of C-MYC 
usually suppresses this protein (Gaidano et al 1998, 1997). In diffuse large B cell lymphomas, 
EBV is present in 80% of tumors and generally EBNA-2 and LMP-1 are positive.  
The human herpes virus type 8 (HHV-8) has received increasing attention in the last years, it 
was described in Kaposi´s sarcoma (KS), but it has been constantly found in a special type of 
B lymphoma, i.e., in the primary lymphoma of cavity, where it is thought to have a direct 
etiological role (Cesarman et al 1995). This virus induces latent infection in peripheral B 
lymphocytes, immortalizes these cells in vitro, and induces development of NHL in 
humans. 
It is believe that their presence in KS and LPC is needed but not enough for the 
pathogenesis, and other factors associated to inflammation are needed to develop 
malignancy (Mesri, 1999). 
The virus could adopt a latency stage in CD19+B lymphocytes, it has been identified in 
normal tissues such as the gastrointestinal mucosa, lymph nodes and spleen. Its presence 
has been described in multicentric Castleman´s disease, in angio-immunoblastic 
lymphadenopathy, and in plasmablastic lymphomas (Luppi et al 1999). 
4.4 Genetic alterations 
These occur as posterior events to the polyclonal proliferation of lymphocytes B, they affect 
most frequently: c-MYC (re-arrangement and translocation in 50-75% of occasions, and 
point mutatuions in the second exon), P53(non-sense point mutations or at 16-375 of 
lymphomas), RAS (variable incidence of point mutations), and BCL-6 (rearrangements). 
Molecular alterations affect differently the diverse types of NHL, HIV-infected patients with 
neoplasms have higer frequency of unstability of DNA microsatellites, which indicates that 
they have defficient DNA repair mechanisms (Simonelli et al 2003). 
Changes in the incidence of lymphomas have been observed and marked decrease in 
primary lymphomas of the central nervous system has been confirmed. Incidence of 
systemic lymphomas has also varied, although there is no consensus among the different 
research groups (Skies and Crosby 2003).  
The most frequent NHL varieties are the diffuse large B cell lymphoma, the Burkitt 
lymphoma, the plasmablastic and the primary effusion lymphomas.  
Morphologically lymphomas in HIV patients are similar to those described in patients 
without viral infection. Diffuse large B cell lymphoma, without further specification, is 
defined as a heterogeneous group of lymphoid neoplasms of B cells with a diffuse growth 
pattern. According to current WHO classification (Swerdlow et al 2008), it is classified by 
morphological appearance in the following varieties: centroblastic, immunoblastic and 
anaplastic. Immunoblastic variant is more common in patients with HIV and is 
characterized by large cells, abundant cytoplasm and evident nucleoli center, about 90% of 
the cells must have these features to be called immunoblastic (Fig 7).  
They are classified by their expression to different immunohistochemical markers such as CD 
5 positive, those originated from the germinal center when tumor cells express CD10 and/or 
bcl6, and in non-germinal center originated when they do not express CD 10 (Hans et al 2003). 
Characterstically, they always express B markers such as: CD 19, CD 20 and CD 79a 
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Fig. 7. Large B cell  lymphoma (H-E  10X) 
The plasmablastic lymphoma is characterized by diffuse proliferation o large cells that 
resemble immunoblasts, but the tumor cells have the immunophenotype of plasmatic cells. 
It was originally described in the oral cavity but can occur at any site. The express CD 138, 
CD 38, MUM-1 and Eber. 
Primary effusion lymphoma is a large B cell neoplasm that occurs in the serose tissues 
without a palpable tumor mass. Co-infection with the EBV can be observed and it is the 
lymphoma most strongly associated with the HHV-8. The most affected sites are the pleural, 
pericardial and peritoneal cavities. According to phenotype, they express pan-B markers. 
The Burkitt lymphoma associated to HIV generally occurs in lymph node and is 
characterized by the presence of monotonous o uniforme tumor cells with small nucleoli 
and fine and dispersed chromatine; cells are medium-sized and the classical “starry sky” 
pattern is observed quite frequently, characterized by the presence of abundant 
marcrophages with apoptotic cells. Through immunophenotype they are positive to pan B,   
CD 10, bcl 6, CD-38, and CD-43 markers. They depict a high cellular proliferation index 
(100%) and do not express TdT or bcl 2. (Swerdlow et al 2008). 
Other lymphomas may also occur in patients with HIV, and one of the common extranodal 
sites is the gastrointestinal tract where the above mentioned types of lymphoma can occur, 
as well as small lymphocyte lymphomas such as the MALT-type B-cell lymphoma of the 
marginal zone (Ho- Yen et al 2007). 
T lineage lymphomas are rare and have been, reported in isolated cases of patients  
with HIV. In a series of nose, palate and oropharynx lymphomas in a hospital in Mexico City, 
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two male homosexual patients 54 years of age were found with nasal typeT/NK lymphoma, 
as known this is a lymphoma with certain regional characteristics and widely associated with 
EBV. (Romero et al 2008)(Figs 8 and 9), other peripheral T lymphomas may be present in these 
patients, clinically they tend to infiltrate skin and bone marrow more frequently but there is 
little information on treatment outcomes in the era of HAART (Arzoo et al 2004).  
4.5 Hodgkin lymphoma 
The Hodgkin lymphoma (LH) in HIV-infected patients can be seven-times more frequent that 
in healthy individuals, particularly in Europeans and Northeamericans (Tirelli et al 1995; 
Knowles et al 1988). Diagnostic criteria for LH are the same for either HIV or healthy 
individuals. However the most frequent subytype in HIV patients comprises the most 
unfavorable variants such as mixed cellularity and depletion of lymphocytes of the clasical 
HL(p<0.01), other features published are the abundance of a proliferation of the fibrohistiocyte 
stroma and a higher perecentage of Reed-Sternberg cells (Ree et al 1991; Bellas et al 1996). 
 
 
Fig. 8. Extranodal NK/T-cell lymphoma, nasal type. There is a lymphoid infiltrate, with 
angio-invasion and prominent coagulative necrosis ( H-E 10X) 
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Fig. 9. In situ hybridization for EBV-encoded RNA (EBER), in this nasal tumor, practically all 
the neoplastic cells show nuclear labeling. (40X) 
Relation between EBV infection and the origin of LH seems to be tighter in HIV infected 
patients than in the reamainder LH cases (Ree et al 1991). The combined use of in situ 
hybridation techniques, immunohistochemistry to determine the expression of LMP-1, 
indicative of latent EBV infection, and other molecular biology techniques have 
demonstrated that 78 to 100% of HIV+HL cases are associated to the EBV. On the other side, 
studies on the expression of bcl-6, generally expressed in centro-follicular lymphocytes, and 
of a proteglycan (CD138/Syndecan-1), characteristic of post-germinal differentiation have 
demonstrated the Reed-Sternberg cells of HL associated with HIV are post-germinal 
lymphocytes, in contrast to what occurs with the neoplastic cells of HL patients not HIV-
infected (Carbone et al 1999). Incidence of HL in HIV patients has not increased (Seaberg et 
al 2010). 
4.6 Other malignancies (Carcinoma)  
Squamous cells carcinoma of different sites in HIV patients. Despite the association of 
infection with the human papiloma virus in HIV patients and cancer at different sites, such 
as anal, cervix, lip, conjunctiva, penis, vagina, and vulva, has increased the role of 
immunodepression in this type of epithelial cells is still unknown, nor do we know their 
incidence after antiretroviral drugs use. In a recently performed study by (Chaturvedi et al 
2009), these authors found statistical significance between the number of CD4 lymphocytes 
and anal, vaginal, and vulva cancer, but not when dealing with cervical cancer. 
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Fig. 10. Anal squamous cell carcinoma. (H-E 10X) 
Anal cancer is a rare disease, it corresponds to only 4% of the malignant tumors of the 
gastrointestinal tract (Clark et al 2004). 
Squamous cell carcinoma is by far the most common type of anal malignancy (Ryan and 
Mayer 2000). The incidence of anal carcinoma is higher in those who practise ano-receptive 
intercourse, those who are HIV-positive and in transplant recipients. Anal intraepithelial 
neoplasia is a premalignant lesion associated with human papilloma virus, thought to 
develop into invasive squamous cell carcinoma in a manner analogous to the progression of 
cervical intraepithelial neoplasia to cervical squamous cell carcinoma. Bleeding and pain are 
common in anal carcinoma. Anal carcinomas are dividided into keratinized and non 
keratinized tumors with subtypes of the non keratinized tumors referred to as clacogenic or 
basaloid. The behavior of these subtypes is similar. Irrespective of the anatomic and 
histologic classification, anal squamous cell carcinoma can be thought of as a tumor that 
may show squamous, basaloid, ductal or a mixed morphology. The type 16 is the most 
frequently isolated type with 40-75% of all HPV positive samples. Verrucous carcinoma is a 
low-grade well-differentiated squamous cell carcinoma characterized by papillomatosis, 
acnathosis and boroad down growths with keratin clefts. The incidence of this disease is 
increasing in the United States, Europe and South America, especially in the male 
population.  
In Mexico, cervical-uterine cancer remains a public health problem and patients infected 
with HIV, are at high risk of being infected with HPV, particularly with high risk subtypes, 
and develop invasive  cervical carcinoma (Volkow et al 2001), that occurs in young women 
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between the third and fourth decade of life and is clinically more aggressive. The most 
common morphological type is squamous cell carcinoma and there are no unique 
characteristics among carcinomas from patients without HIV. 
Vulvar cancer is likely to be a multifactorial tumor in which recognized risk factors include 
advanced age, HPV infection, smoking habits, HIV infection, previous VIN (vulvar 
intraepithelial neoplasm) lesions, lichen sclerosus in the vulva and immunessupression. The 
expected proportion of vulvar cancers attributable to HPV lies within a range of 15-40% 
with a summary point estimate of 14%. Nevertheless, distinct subtypes of squamous cell 
carcinomas (SCCs) are recognized with different prevalence of HPV infection, but in HIV 
infection most patients are HPV positive. The warty and basaloid subtypes which account 
for 10-25% of all vulvar cancers have a range of HPV positivity of 59-90%, and the 
prevalence in the most common conventional squamous cell carcinoma the HPV prevalence 
is a low as 10-15% (Kurman et al 1993) 
Recognized risk factor for vaginal cancer are HPV infection, exposure during pregnancy to 
diethylstilbestrol, previous history of cervical cancer and previous history or VAIN lesions. 
The most frequently isolated HPV types identified in cancers of the vagina are 16 and 18 
(Srodon et al. 2006).  
Other types of tumors have been reported in HIV patients, such as smooth muscle tumors 
(leiomyomas and leiomyosarcomas) related to EBV in children (Chadwick et al 1990) 
5. Conclusions 
In conclusion, despite the low morbidity and mortality of HIV infected patients due to 
opportunistic infections, such as atypical mycobacteral and some fungal infections, 
particularly in developed countries and thanks to the antiretroviral therapy, there is still 
much to learn, especially because of the resistant HIV strains and the resistance to antibiotic 
therapy of some opportunistic pathogens frequently occurring in this type of patients. It 
must also be taken into account that there are other infectious agents that may arise and it is 
necessary to know their clinical and diagnostic characteristics to be able to provide specific 
treatment. Neoplasms in HIV patients are well identified, however, with time and from 
future research, new types can up particularly in geographical regions were some oncogenic 
viruses are prevalent. 
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